What are the clinical presentation and diagnostic approach for bronchiectasis?

Clinical Presentation and Diagnosis of Bronchiectasis

Clinical Presentation

Bronchiectasis presents with chronic productive cough and recurrent respiratory infections, and diagnosis requires both radiological confirmation via CT scan and the presence of characteristic clinical symptoms. 1, 2

Cardinal Symptoms

• Chronic productive cough with mucopurulent or purulent sputum is the hallmark clinical feature that should prompt investigation. 3, 2
• Recurrent chest infections occurring repeatedly over time, particularly when associated with positive sputum cultures for potentially pathogenic microorganisms. 3
• Hemoptysis may occur as a presenting symptom in some patients. 4
• Dyspnea and hypoxia can develop, particularly in more advanced disease. 4

High-Risk Populations Requiring Lower Threshold for Investigation

The British Thoracic Society identifies specific populations where investigation should be pursued more aggressively: 3, 2

• COPD patients with ≥2 exacerbations in the preceding 12 months AND positive sputum cultures for potentially pathogenic microorganisms while stable. 3, 2
• Asthma patients with severe or poorly-controlled disease despite appropriate therapy. 3, 2
• Rheumatoid arthritis patients presenting with chronic productive cough or recurrent chest infections. 2
• Immunocompromised patients, including those with HIV-1 infection, solid organ or bone marrow transplant recipients, and patients with history of immunosuppressive therapy for lymphoma or vasculitis. 3, 2
• Chronic rhinosinusitis patients who develop chronic productive cough or recurrent chest infections. 3
• Inflammatory bowel disease or connective tissue disease patients with chronic productive cough or recurrent chest infections. 3, 2
• Otherwise healthy individuals with cough persisting longer than 8 weeks, especially with sputum production or history of an appropriate trigger. 3, 2

Critical Pitfall to Avoid

• Do not rely on physical examination alone to diagnose or exclude bronchiectasis, as radiological bronchiectasis may exist in asymptomatic individuals, particularly the elderly. 3, 2
• Physical examination findings should prompt appropriate imaging rather than serve as diagnostic criteria. 2

Diagnostic Approach

Initial Imaging

Obtain a baseline chest X-ray first, but recognize its limited sensitivity (≈87.8%) and specificity (≈74.4%) compared with CT scanning. 1

• Chest X-ray serves primarily as an initial screening tool but cannot reliably exclude bronchiectasis. 1, 2
• Baseline imaging must be obtained during clinically stable disease to ensure optimal diagnostic accuracy and allow reliable serial comparison. 1, 2

Definitive Diagnostic Imaging

Perform thin-section, non-contrast chest CT scan to confirm bronchiectasis—this is the diagnostic procedure of choice. 1, 2

CT Diagnostic Criteria (All Three Are Diagnostic)

The following CT findings establish the diagnosis of bronchiectasis: 1

1. Broncho-arterial ratio exceeds 1 (airway lumen larger than the adjacent pulmonary artery). 1
2. Absence of normal bronchial tapering from central to peripheral lung. 1
3. Airways visible within 1 cm of the costal pleural surface or touching the mediastinal pleura. 1

Supportive CT Findings

• Indirect signs include bronchial wall thickening, mucus impaction, and mosaic perfusion/air-trapping on expiratory scans. 1

Additional Diagnostic Procedures in Specific Circumstances

• Consider bronchoscopy for patients with localized disease to rule out an endobronchial lesion or foreign body as the cause. 3
• Bronchial aspiration or bronchial wash targeting areas of bronchiectasis should be considered in patients who do not expectorate, particularly helpful for diagnosing nontuberculous mycobacterial pulmonary disease. 3

Etiological Investigation

Conduct a systematic diagnostic work-up for underlying disorders in all patients without an obvious cause, as identification can lead to disease-modifying treatments. 1

Specific Conditions Requiring Targeted Testing

Condition	When to Suspect	Diagnostic Test	Management Implication
Cystic fibrosis	Young patients, upper lobe predominant disease [4]	Sweat chloride test (pilocarpine iontophoresis) [1]	Disease-specific therapies (CFTR modulators) [1]
Hypogammaglobulinemia	Recurrent infections, low immunoglobulin levels	IgG <5 g/L, IgA <0.1 g/L with poor vaccine response [1]	Intravenous immunoglobulin replacement [1]
ABPA	Mid-upper lobe bronchiectasis [4], asthma history	CT features suggestive of ABPA [1]	Systemic corticosteroids [1]
NTM infection	Upper lobe or nodular bronchiectasis pattern [4]	Characteristic CT patterns in appropriate clinical context [1]	Targeted antimicrobial therapy [1]
Alpha-1 antitrypsin deficiency	Lower lobe predominant disease	CT findings raising suspicion [1]	Referral for confirmatory testing [1]
Primary ciliary dyskinesia	Lower lobe disease, history of chronic otitis [4]	CT findings raising suspicion [1]	Referral for disease-specific care [1]

Additional Laboratory Testing

• Serum protein electrophoresis should be performed in all patients with bronchiectasis with raised immunoglobulins. 3
• Consider HIV-1 serology depending on prevalence and clinical features suggestive of increased risk of retroviral infection. 3
• Investigations for reflux and aspiration should be undertaken only in symptomatic patients or where there are other suggestive clinical features. 3

Severity Assessment

• Consider using the bronchiectasis severity index to help guide management decisions. 3
• Presence of bronchiectatic changes in three or more lobes on CT is associated with higher rates of exacerbations, hospitalizations, and mortality. 1